Hudock, Inc. Teva Pharmaceutical Industries LTD Transaction History

Hudock, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$8.61 - $11.04 $861 - $1,104	-100 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$8.12 - $13.12 $9,946 - $16,071	-1,225 Reduced 92.45%	100 $1,000
Q1 2020 Apr 27, 2020	BUY	$6.69 - $13.45 $8,195 - $16,476	1,225 Added 1225.0%	1,325 $11,000
Q4 2019 Jan 21, 2020	SELL	$6.53 - $10.72 $653 - $1,072	-100 Reduced 50.0%	100 $0
Q3 2019 Oct 31, 2019	SELL	$6.16 - $9.6 $1,848 - $2,880	-300 Reduced 60.0%	200 $1,000
Q1 2019 Apr 23, 2019	SELL	$15.58 - $20.01 $1,558 - $2,001	-100 Reduced 16.67%	500 $7,000
Q3 2018 Oct 16, 2018	SELL	$21.06 - $25.65 $2,843 - $3,462	-135 Reduced 18.37%	600 $12,000
Q2 2018 Aug 01, 2018	SELL	$16.77 - $24.71 $519 - $766	-31 Reduced 4.05%	735 $17,000
Q1 2018 Apr 27, 2018	SELL	$16.68 - $22.07 $25,553 - $33,811	-1,532 Reduced 66.67%	766 $13,000
Q4 2017 Jan 30, 2018	SELL	$11.23 - $19.1 $6,659 - $11,326	-593 Reduced 20.51%	2,298 $43,000
Q3 2017 Oct 27, 2017	BUY	$15.41 - $32.17 $2,527 - $5,275	164 Added 6.01%	2,891 $50,000
Q2 2017 Aug 08, 2017	BUY	N/A	2,727	2,727 $90,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

Stay updated on Hudock, Inc. with notifications on news.